Adisseo acquires FRAmelco Group

According to the press release, Adisseo hopes the transaction will boost Specialties growth in order to become one of the world leaders in the field of specialty feed ingredients in animal nutrition. Additionally, the company reckons the acquisition will reinforce its position in the promising Health by Nutrition market segment.

Family-owned multinational FRAmelco Group is headquartered in the Netherlands and operates 3 plants, located in the Netherlands, Spain and Thailand. The business generates gross sales of about €30 million per year, most of which comes from the sales of Glycerides (short- and medium-chain fatty acids) and Lysolecithins. The group employs 75 persons, is active in over 60 countries and is rapidly expanding.

Commenting on the acquisition, Adisseo CEO Jean-Marc Dublanc said: “Today we take another step forward in implementing our growth strategy on Specialties. We look forward to welcoming the FRAmelco management and employees with their great knowledge and expertise.”

FRAmelco’s industrial footprint, its product range, its technologies, its species addressed, and its target markets complement Adisseo’s. The press release states that this will allow the combined business to implement integrated solutions and offer even more value to customers whose aim is to reduce antibiotic usage and enhance animal resilience.

The acquisition of FRAmelco is bringing products, solutions and know-how to better address our customers’ current and future needs,” said Dublanc.

Lars Snijders, CEO of FRAmelco, added: “We are excited to become a part of Adisseo because both companies are driven by the same ambition – to deliver the most innovative and sustainable feed solutions to customers.

“We are proud of what we have achieved in recent years, bringing solutions and value to our clients through our Glycerides and Lysolecithins technologies.

“By combining our strengths with those of Adisseo, we can jointly accelerate success.”